<DOC>
	<DOCNO>NCT01888822</DOCNO>
	<brief_summary>The trial aim assess value two-regimen antibiotic prophylaxis versus placebo elective laparoscopic cholecystectomy .</brief_summary>
	<brief_title>Antibiotic Prophylaxis Laparoscopic Cholecystectomy</brief_title>
	<detailed_description>All patient enrol submit laparoscopic cholecystectomy . The primary aim trial assess role prophylactic i.v . infusion ampicillin-sulbactam , ciprofloxacin , placebo reduce rate surgical site infection .</detailed_description>
	<mesh_term>Cholelithiasis</mesh_term>
	<mesh_term>Cholecystolithiasis</mesh_term>
	<mesh_term>Gallstones</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Ciprofloxacin</mesh_term>
	<mesh_term>Sulbactam</mesh_term>
	<mesh_term>Sultamicillin</mesh_term>
	<mesh_term>Ampicillin</mesh_term>
	<criteria>elective laparoscopic cholecystectomy ; patient suffer gallbladder stone , chronic cholecystitis , cholesterolosis , gallbladder polyp . acute cholecystitis ; acute cholangitis ; acute pancreatitis ; pregnant lactating woman ; antibiotic allergy ; antibiotic therapy within 48 hour 7 day prior surgery ; clinically active infection moment surgery ; evidence common bile duct stone ; contraindication laparoscopic cholecystectomy ; additional procedure ; indication obligatory antibiotic prophylaxis medical condition different biliary disease ( immunosuppression , corticoid use , etc ) . patient unable give inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Laparoscopic cholecystectomy</keyword>
	<keyword>Prophylactic antibiotic</keyword>
</DOC>